Magle Chemoswed

Magle Chemoswed is a CDMO and CMO offering analytical and process development, solid-state services, cGMP and ISO 13485 manufacturing, freeze drying, small-scale vial fill and finish, and inhalation support. It also supplies active pharmaceutical ingredients such as warfarin sodium, melperone hydrochloride, isradipine and amantadine sulfate.

It serves pharmaceutical and medical device companies on a contract basis, taking customer and its own products from development through manufacturing. The website describes a partnership-based development method and its own technology platform based on starch microspheres.

The company is based in Malmö, Sweden. Its roots go back to Chemoswed, founded in 1944, and it was formed under the current name in 2017 when Magle Life Sciences acquired Chemoswed. The website states it employs around 70 people and currently lists job openings including a QA Specialist and a manufacturing operator role at Magle Biopolymers in Hårlev.

Product: Contract development and manufacturing services for pharmaceutical and medical device companies, plus APIs.